Vanta Bioscience share news, announcements and annual reports
BSE: 540729Healthcare ServicesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹20.40.
30 Oct: open ₹20.39, high ₹20.39, low ₹20.39
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,396th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 133.90
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.68
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.80
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 750
Vanta Bioscience share news and announcements
251 announcements, routine notices left out, newest first. Page 2 of 6.
Sep 2024
Aug 2024
18 Aug · Intimation Of Submission Of Application To BSE For Reclassification From 'Promoter' Category To 'Public' Category
Jul 2024
19 Jul · Results
19 Jul · Board meeting
18 Jul · Board meeting
Meeting on 19 Jul 2024: audited results10 Jul · Board meeting
Meeting on 17 Jul 2024: audited results
Apr 2024
2 Apr · Business
1 Apr · Management
Dec 2023
1 Dec · Business
Nov 2023
14 Nov · Change In Designation Of Dr. Vyasmurti Madhavrao Shingatgeri (DIN 07728757) From Whole Time Director To Non-Executive Director W.E.F 14.11.2023.
14 Nov · Board meeting
8 Nov · Board meeting
Meeting on 14 Nov 2023: half yearly results2 Nov · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Oct 2023
1 Oct · Meeting
Sep 2023
6 Sep · Meeting
Aug 2023
10 Aug · Results
10 Aug · Results
4 Aug · Board meeting
Meeting on 10 Aug 2023: audited results and half yearly results
Jul 2023
10 Jul · Management
May 2023
30 May · Announcement under Regulation 30 (LODR)-Meeting Updates
22 May · Board meeting
Meeting on 30 May 2023: half yearly results and audited results
Apr 2023
Mar 2023
Feb 2023
15 Feb · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Jan 2023
21 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
14 Jan · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
11 Jan · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Dec 2022
31 Dec · Meeting
14 Dec · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
7 Dec · Meeting
Nov 2022
27 Nov · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
24 Nov · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
9 Nov · Board meeting
Meeting on 14 Nov 2022: half yearly results
Oct 2022
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0